Oncology Clinical Trials in Spokane, WA
As of August 2026, 49 paid clinical trials are recruiting for Oncology in Spokane, Washington. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
49 clinical trials for Oncology
·Clear filters·A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
A Study of YL201 in Patients With Advanced Solid Tumors
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
A Phase I/II, Open-label Study to Investigate the Safety, Tolerability, PK, and Preliminary Efficacy of FB849
A Study Evaluating the Safety and Efficacy of HB0036 in Subjects With Advanced Solid Tumors
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Project: Every Child for Younger Patients With Cancer
Top Research Study Locations in Spokane
Researchers run research studies in Spokane, WA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Providence Sacred Heart Medical Center and Children's Hospital | Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia, Malignant Solid Neoplasm | 29 |
| Cancer Care Northwest - Spokane South | Malignant Solid Neoplasm, Ovarian Carcinoma, Acute Lymphoblastic Leukemia | 24 |
| Cancer Care Northwest-North Spokane | Malignant Solid Neoplasm, Ovarian Carcinoma, Acute Lymphoblastic Leukemia | 24 |
| Cancer Care Northwest-Valley | Malignant Solid Neoplasm, Ovarian Carcinoma, Acute Lymphoblastic Leukemia | 22 |
| Spokane Eye Clinical Research | Amblyopia, Age-Related Macular Degeneration, Age-related Macular Degeneration (AMD) | 9 |
| Inland Northwest Research | Parkinson Disease, Parkinson's Disease, Deep Brain Stimulation | 6 |
| Providence Sacred Heart Medical Center | Alport Syndrome, Central Line Associated Blood Stream Infections (CLABSI), Cirrhosis | 6 |
| Summit Cancer Centers | Adenoid Cystic Carcinoma, Advanced Metastatic Castration Resistant Prostate Cancer, Advanced Solid Tumor | 5 |
| Cancer Care Northwest | Advanced/Metastatic Solid Tumors, Cancer, Colorectal Cancer | 5 |
| Dermatology Specialists of Spokane | Alopecia Areata, Alopecia Areata (AA), Hidradenitis Suppurativa (HS) | 5 |
| Providence Sacred Heart Medical Center & Children's Hospital | Fallopian Tube Cancer, Endometrioid Ovarian Cancer, Epithelial Ovarian Cancer | 5 |
| Spokane Urology | High-Risk Non-Muscle-Invasive Bladder Cancer, Metastatic Castration-Resistant Prostate Cancer (mCRPC), Non-Muscle Invasive Bladder Neoplasms | 5 |
| Washington State University College of Pharmacy and Pharmaceutical Sciences | Interaction, Herbal Interaction | 4 |
| Premier Clinical Research | Actinic Keratosis, Plaque Psoriasis | 3 |
| Providence Medical Research Center | Cystic Fibrosis, Glomerulosclerosis, Focal Segmental, Infections | 3 |
| Medical Oncology Associates - Spokane | CLL, CLL (Chronic Lymphocytic Leukemia), CLL / SLL | 3 |
| Arthritis Northwest | Acute Gout Flare, Arthritis, Gout | 2 |
| Kingfisher Cooperative | Alzheimer Disease, Cervical Dystonia | 2 |
| Principle Research Solutions | Alopecia Areata, Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate | 2 |
| Providence Medical Group, Cystic Fibrosis Clinic | Cystic Fibrosis, Cystic Fibrosis Pulmonary Exacerbation | 2 |
| Sleep and Performance Research Center | Cataplexy, Circadian Misalignment, Circadian Rhythm | 2 |
| Spokane Joint Replacement Center | Osteoarthritis, Symptomatic Venous Thromboembolism (VTE) | 2 |
| Summit Cancer Centers - North Spokane | B-cell Non Hodgkin Lymphoma, Hepatocellular Carcinoma | 2 |
| Velocity Clinical Research - Spokane | Atherosclerotic Cardiovascular Disease, Diabetic Peripheral Neuropathic Pain, Obesity | 2 |
| Velocity Clinical Research-Spokane-69716 | Liver Fibrosis, Metabolic Dysfunction Associated Steatohepatitis, Metabolic Dysfunction Associated Steatohepatitis (MASH) | 2 |
Active & Upcoming Studies in Spokane (2026)
Recruiting trials in Spokane grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (74 active studies)
- A Study of ARC-02 in B-cell NHL · Phase 1 · Taiho Oncology, Inc.
- Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia · Phase 3 · Children's Oncology Group
Neurology & pain (10 active studies)
- Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease · Phase 2 · Hillhurst Biopharmaceuticals, Inc.
- A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3) · Phase 3 · Bristol-Myers Squibb
Eye & vision (7 active studies)
- A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration · Phase 3 · Amgen
- A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002) · Phase 2, Phase 3 · EyeBiotech Ltd.
Diabetes & metabolic (6 active studies)
- Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity · Phase 3 · Amgen
- Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease · Phase 3 · Alessandro Doria
Cardiovascular (4 active studies)
Pediatric (1 active study)
- NEPTUNE Match Study · University of Michigan
Common conditions studied in Spokane
- Head and Neck Squamous Cell Carcinoma (5 active studies)
- Malignant Solid Neoplasm (5 active studies)
- Acute Myeloid Leukemia (4 active studies)
- Breast Cancer (4 active studies)
- Chronic Lymphocytic Leukemia (4 active studies)
- Fallopian Tube Cancer (4 active studies)
Leading research sponsors in Spokane
- Children's Oncology Group
- Washington State University
- National Cancer Institute (NCI)
- Alliance for Clinical Trials in Oncology
- Bristol-Myers Squibb
Frequently asked questions
How many paid clinical trials are currently recruiting in Spokane?
There are approximately 191 recruiting clinical trials in Spokane, Washington listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Spokane pay participants?
Most recruiting trials in Spokane compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Spokane?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Spokane?
The most common conditions under active study in Spokane include Head and Neck Squamous Cell Carcinoma (5), Malignant Solid Neoplasm (5), Acute Myeloid Leukemia (4), Breast Cancer (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Spokane?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Spokane on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Spokane?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Spokane?
Recruiting research sites in Spokane include Providence Sacred Heart Medical Center and Children's Hospital, Cancer Care Northwest - Spokane South, Cancer Care Northwest-North Spokane, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Spokane right now?
The largest active categories in Spokane are Cancer & tumors (74), Neurology & pain (10), Eye & vision (7). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.